The provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry has signed another agreement, in addition to the contract win announcement on 28 June 2019, to work with Bicycle Therapeutics plc (Nasdaq: BCYC) and Cancer Research UK. This is the second project with Bicycle Therapeutics within a fortnight and the first time working directly with Cancer Research UK, the UK's leading cancer research charity
10 Jul 2019
Agreement with Bicycle Therapeutics and Cancer Research UK
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Agreement with Bicycle Therapeutics and Cancer Research UK
Physiomics Plc (PYC:LON) | 1.3 0 13.0% | Mkt Cap: 1.76m
- Published:
10 Jul 2019 -
Author:
Darshan Patel -
Pages:
6
The provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry has signed another agreement, in addition to the contract win announcement on 28 June 2019, to work with Bicycle Therapeutics plc (Nasdaq: BCYC) and Cancer Research UK. This is the second project with Bicycle Therapeutics within a fortnight and the first time working directly with Cancer Research UK, the UK's leading cancer research charity